USA - NYSE:EHC - US29261A1007 - Common Stock
The current stock price of EHC is 115.6 USD. In the past month the price decreased by -5.96%. In the past year, price increased by 16.94%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 17.87 | 108.18B | ||
| THC | TENET HEALTHCARE CORP | 12.78 | 17.52B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 10.79 | 14.28B | ||
| ENSG | ENSIGN GROUP INC/THE | 28.81 | 10.37B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.92 | 2.51B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.42B | ||
| SGRY | SURGERY PARTNERS INC | 20.19 | 2.02B | ||
| NHC | NATIONAL HEALTHCARE CORP | 19.7 | 2.05B | ||
| ARDT | ARDENT HEALTH INC | 7.85 | 2.01B | ||
| PACS | PACS GROUP INC | 16.2 | 1.91B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 7.04 | 1.68B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 15.63 | 1.67B |
Encompass Health Corp. engages in the provision of post-acute healthcare services. The company is headquartered in Birmingham, Alabama and currently employs 23,564 full-time employees. The firm provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. The company operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. The company operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
ENCOMPASS HEALTH CORP
9001 Liberty Pkwy
Birmingham ALABAMA 35242 US
CEO: Mark J. Tarr
Employees: 25191
Phone: 12059677116
Encompass Health Corp. engages in the provision of post-acute healthcare services. The company is headquartered in Birmingham, Alabama and currently employs 23,564 full-time employees. The firm provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. The company operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. The company operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
The current stock price of EHC is 115.6 USD. The price increased by 0.34% in the last trading session.
ENCOMPASS HEALTH CORP (EHC) has a dividend yield of 0.66%. The yearly dividend amount is currently 0.62.
EHC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
The PE ratio for ENCOMPASS HEALTH CORP (EHC) is 22.36. This is based on the reported non-GAAP earnings per share of 5.17 and the current share price of 115.6 USD.
ENCOMPASS HEALTH CORP (EHC) will report earnings on 2026-02-04, after the market close.
You can find the ownership structure of ENCOMPASS HEALTH CORP (EHC) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to EHC. When comparing the yearly performance of all stocks, EHC turns out to be only a medium performer in the overall market: it outperformed 60.97% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to EHC. While EHC has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months EHC reported a non-GAAP Earnings per Share(EPS) of 5.17. The EPS increased by 22.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.18% | ||
| ROA | 7.67% | ||
| ROE | 22.82% | ||
| Debt/Equity | 1.02 |
17 analysts have analysed EHC and the average price target is 141.87 USD. This implies a price increase of 22.72% is expected in the next year compared to the current price of 115.6.
For the next year, analysts expect an EPS growth of 20.76% and a revenue growth 10.92% for EHC